Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Emergent BioSolutions Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Emergent BioSolutions Inc. April 30, 202595.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Emergent BioSolutions Inc. | Open-market sale | −16,145 | $8.36 | $134,972 |
| May 1, 2026 | Emergent BioSolutions Inc. | Open-market sale | −1,057 | $8.97 | $9,481 |
| Apr 30, 2026 | Emergent BioSolutions Inc. | Grant or award | +25,344 | — | — |
| Aug 15, 2025 | Emergent BioSolutions Inc. | Open-market sale | −7,086 | $8.87 | $62,853 |
| Apr 30, 2025 | Emergent BioSolutions Inc. | Grant or award | +34,403 | — | — |
| Mar 12, 2025 | Emergent BioSolutions Inc. | Open-market sale | −10,000 | $5.73 | $57,300 |
| Jun 4, 2024 | Emergent BioSolutions Inc. | Open-market sale | −10,000 | $6.11 | $61,100 |
| May 29, 2024 | Emergent BioSolutions Inc. | Open-market sale | −1,830 | $4.61 | $8,436 |
| May 23, 2024 | Emergent BioSolutions Inc. | Grant or award | +17,430 | — | — |
| May 21, 2024 | Emergent BioSolutions Inc. | Open-market sale | −1,089 | $5.78 | $6,294 |
| Jun 2, 2023 | Emergent BioSolutions Inc. | Open-market sale | −1,830 | $8.35 | $15,281 |
| May 25, 2023 | Emergent BioSolutions Inc. | Grant or award | +33,847 | — | — |
| May 25, 2023 | Emergent BioSolutions Inc. | Open-market sale | −1,700 | $8.38 | $14,246 |
Questions about Kathryn C. Zoon
What boards is Kathryn C. Zoon on?
Kathryn C. Zoon sits on the board of Emergent BioSolutions Inc.
How long has Kathryn C. Zoon served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.